SCHEMBL19873401

SCHEMBL19873401

CN1CCCC1CCNc1nc(-c2ccc3ccccc3c2C=O)nc(C(Cl)(Cl)Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH1 P35367 2/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.40
▸ HRH2 P25021 1/20 0.40
▸ ACP1 P24666 2/20 0.40
▸ RAD52 P43351 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ ERAP1 Q9NZ08 1/20 0.39
▸ NPY5R Q15761 1/20 0.35
▸ KAT2B Q92831 1/20 0.35
▸ ADRA1B P35368 2/20 0.35
▸ ACKR3 P25106 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ CAMK2D Q13557 1/20 0.35
▸ NMT1 P30419 1/20 0.35
▸ POLR1A O95602 1/20 0.34
▸ HTR7 P34969 2/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ HTR1D P28221 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19873425 0.83 ACP1 (0.40) HRH3ACP1NPC1RAB9AKAT2B
SCHEMBL17721582 0.82 ACP1 (0.45) HRH1HRH3HRH2ACP1RAD52
SCHEMBL16928554 0.81 HRH2 (0.43) HRH1HRH3HRH2ACP1RAD52
SCHEMBL19873416 0.81 NPY5R (0.37) NPY5RHTR2AHTR2C
SCHEMBL16928011 0.80 ACP1 (0.48) HRH1HRH3HRH2ACP1RAD52
SCHEMBL16928222 0.80 ACP1 (0.45) HRH1HRH3HRH2ACP1RAD52
SCHEMBL16928548 0.79 NMT1 (0.48) HRH1HRH3HRH2ACP1RAD52
SCHEMBL16928133 0.79 CHRM3 (0.39) HRH1HRH3HRH2ACP1RAD52
SCHEMBL16928309 0.79 ACP1 (0.47) HRH1HRH3HRH2ACP1RAD52
SCHEMBL19873411 0.78 BRD4 (0.36) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970153-B1 TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS THE US SECRETARY OF THE ARMY ON BEHALF OF WALTER REED ARMY INSTITUTE OF RESEARCH (US) 2018-02-21 — — EP claimed
Send feedback